SeedHealthTech
RxMen Secures Rs 5 Crore Seed Funding for Men's Health Revolution
Investorsync desk1 min read
Deal sheet
Rs 5 Crore
- Stage
- Seed
- Sector
- HealthTech
- Announced
- 4 September 2025
RxMen has raised Rs 5 crore in seed funding led by Inflection Point Ventures (IPV), with participation from SPA Family Ventures, Seven Square Ventures, and a grant from Prosus Group.
Founded by Shailja Mittal in 2023, Delhi, RxMen is building a clinic-led men’s health platform offering root-cause treatment for sexual health, hormones, skin, stress, and sleep.
The fresh capital will be used for brand building, launching RxMen products, and opening co-branded clinics.
- In 20 months, it has grown 100x in revenue, reporting an MRR of $70,000 (Aug 2025) and projecting an ARR of $1.7M by FY26.
- It has delivered 30,000+ consultations, handling 6,000 monthly via 30 specialists in urology, psychiatry, sexology, and therapy.
Source: company announcement. First posted on the Investorsync LinkedIn page.
From InvestorDB